Sign in
BSX-BOSTON SCIENTIFIC CORP
Boston Scientific Surges 60.4% Over Last Year, Earns 'Strong Buy' Rating Amid Record Performance and Positive Earnings Outlook
Member Only Article
Friday
21 February, 2025
Boston Scientific has achieved an impressive 60.4% increase in share price over the past year, outpacing the industry significantly. With strong revenue growth and a bullish earnings outlook, can this medical device leader maintain its momentum in a challenging market?
Article Impact Score
0
50
100
Underperform
Bearish
Neutral
Bullish
Outperform
0
Key Takeaways
- Loading...
Most Read
Join Foliko Premium!
Unlock the entire library of Foliko's Generative AI Investment Research. Plus, get AI powered trading signals and stock price predictions.
Go Premium - 7 Day Free Trial